findmyKOL
Clinical trialNCT05438875CompletedPhase 3Interventional

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

SponsorPeking University People's HospitalEnrollment96Purpura, Thrombocytopenic, Idiopathic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Xiaohui Zhang, MD

    Study Principal Investigator Peking University People's Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Tongren Hospital

    Beijing, Beijing Municipality, China

  • Peking University Insititute of Hematology, Peking University People'S Hospital

    Beijing, Beijing Municipality, China

  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University

    Beijing, China

  • Department of Hematology, Beijing Hospital

    Beijing, China

  • Department of Hematology, Senior Department of Hematology, the Fifth Medical Center of Pla General Hospital

    Beijing, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Oct 2022
Primary completion
30 Nov 2024
Completion
30 Nov 2024
Last update posted
9 Sept 2025
Registered enrollment
96
Registry id
NCT05438875

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.